Abstract
Background: Two large-scale genome-wide association studies have identified rs610932 and rs670139 polymorphisms within the MS4A gene cluster as being significantly associated with susceptibility to Alzheimer’s disease (AD) in those with European ancestry. A number of studies have focused on the association between MS4A gene variants and AD in Caucasian and East Asian populations. However, the results remain inconsistent owing to the small sample size in each study.
Objective: We performed a meta-analysis to explore whether rs610932 and rs670139 polymorphisms are associated with susceptibility to AD. Method: 19 studies with 34,119 cases and 56,956 controls concerning rs610932 and 18 studies with 33,622 cases and 55,322 controls concerning rs670139 were included in this meta-analysis by searching the PubMed, MEDLINE, and AlzGene databases. Results: Our results showed significant associations between rs610932 and rs670139 polymorphisms and AD in the pooled population using an additive model. In subgroup analysis, we also identified a significant association of rs610932 in the Asian population under additive [odds ratio=0.82, 95% confidence interval 0.69-0.99, p=0.03] and dominant models (odds ratio=0.82, 95% confidence interval 0.72-0.95, p=0.006), but not under a recessive model. However, no association was found between rs670139 and AD patients using all three of these models in the Asian population. Conclusion: Our results suggest that the rs610932 polymorphism contributes to AD susceptibility in Caucasian and Asian populations. To our knowledge, this is the largest meta-analysis to investigate the association between MS4A gene polymorphisms and AD in Asian and European populations.Keywords: Alzheimer's disease, meta-analysis, MS4A gene cluster, rs610932, rs670139.
Current Alzheimer Research
Title:Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer’s Disease: An Updated Meta-analysis
Volume: 14 Issue: 3
Author(s): Ruixia Zhu, Xu Liu and Zhiyi He
Affiliation:
Keywords: Alzheimer's disease, meta-analysis, MS4A gene cluster, rs610932, rs670139.
Abstract: Background: Two large-scale genome-wide association studies have identified rs610932 and rs670139 polymorphisms within the MS4A gene cluster as being significantly associated with susceptibility to Alzheimer’s disease (AD) in those with European ancestry. A number of studies have focused on the association between MS4A gene variants and AD in Caucasian and East Asian populations. However, the results remain inconsistent owing to the small sample size in each study.
Objective: We performed a meta-analysis to explore whether rs610932 and rs670139 polymorphisms are associated with susceptibility to AD. Method: 19 studies with 34,119 cases and 56,956 controls concerning rs610932 and 18 studies with 33,622 cases and 55,322 controls concerning rs670139 were included in this meta-analysis by searching the PubMed, MEDLINE, and AlzGene databases. Results: Our results showed significant associations between rs610932 and rs670139 polymorphisms and AD in the pooled population using an additive model. In subgroup analysis, we also identified a significant association of rs610932 in the Asian population under additive [odds ratio=0.82, 95% confidence interval 0.69-0.99, p=0.03] and dominant models (odds ratio=0.82, 95% confidence interval 0.72-0.95, p=0.006), but not under a recessive model. However, no association was found between rs670139 and AD patients using all three of these models in the Asian population. Conclusion: Our results suggest that the rs610932 polymorphism contributes to AD susceptibility in Caucasian and Asian populations. To our knowledge, this is the largest meta-analysis to investigate the association between MS4A gene polymorphisms and AD in Asian and European populations.Export Options
About this article
Cite this article as:
Zhu Ruixia, Liu Xu and He Zhiyi, Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer’s Disease: An Updated Meta-analysis, Current Alzheimer Research 2017; 14 (3) . https://dx.doi.org/10.2174/1567205013666161108110828
DOI https://dx.doi.org/10.2174/1567205013666161108110828 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Diabetes NEP-Like Endopeptidases and Alzheimers Disease
Current Alzheimer Research COVID-19: The Significance of Platelets, Mitochondria, Vitamin D, Serotonin and the Gut Microbiota
Current Medicinal Chemistry Blood Pressure and Vascular Alterations with Growth in Childhood
Current Pharmaceutical Design Pharmacological Manipulation of the Vasoconstrictive Effects of Amyloid- β Peptides by Donepezil and Rivastigmine
Current Alzheimer Research Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer’s Diseases
Current Alzheimer Research Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin
Current Neurovascular Research Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology Routine Collection of Patient-Reported Outcomes in an HIV Clinic Setting:The First 100 Patients
Current HIV Research Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology
Current Pharmaceutical Design The Renin-Angiotensin System: New Insight into Old Therapies
Current Medicinal Chemistry Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
Endocrine, Metabolic & Immune Disorders - Drug Targets Identification of Human ABAD Inhibitors for Rescuing Aβ-Mediated Mitochondrial Dysfunction
Current Alzheimer Research Rheumatoid Arthritis and Cardiovascular Risk: Between Lights and Shadows
Current Rheumatology Reviews The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological Diseases
Current Pharmaceutical Design Programmed Cell Death Mechanisms in Neurological Disease
Current Molecular Medicine Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis
Current Drug Targets New Insight into the Mechanisms of <i>Ginkgo Biloba</i> Extract in Vascular Aging Prevention
Current Vascular Pharmacology